SCIENCE

Science Mood: Big Doubts on Aliens and AI Math, Quiet Faith in SpaceX

United StatesFri Nov 13 2026

Right now the mood around science leans hard toward doubt. People seem to think the flashy announcements will not land on time. Official confirmation that aliens exist? Most expect that to stay out of reach by the deadline being watched. That view looks firm, not close.

Math is where the doubt runs deepest. Expectations appear to be leaning strongly against anyone declaring the famous fluid-dynamics puzzle solved in the window people are tracking. Machines cracking the toughest prize problems get the same cold reception. An AI finishing the deep number theory riddle, the shape-and-symmetry riddle, or the classic speed-versus-checking riddle? All look unlikely to the crowd. Still, the picture is not completely flat. A quieter cluster of expectations is strengthening around one complexity-theory idea being overturned. That is odd. The same watchers shrug at one dramatic math result while warming to another. It is worth asking what makes a breakthrough feel believable.

Money is where optimism comes easy. SpaceX is broadly favored to end up with the largest public debut by valuation. Rivals from the AI world and the social media world are widely doubted on that same question. Starship test flights are also expected to happen inside the period being followed. So the trust seems to sit with rockets and hardware, not with cosmic reveals or math miracles.

Health counts split people straight down the middle. Some lean heavily toward measles cases in the United States climbing past a set level. Others lean just as hard in the opposite direction. A few of those expectations look clear rather than overwhelming, which hints at a genuine toss-up. That gap is the most interesting part. Everyone is looking at the same outbreaks, yet they walk away with opposite conclusions. Maybe the numbers are noisy. Maybe people are weighing vaccination rates differently. Either way, the disagreement says more about how folks read risk than about the disease itself.

actions